Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;35(1):e15208.
doi: 10.1111/dth.15208. Epub 2021 Nov 30.

Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy

Massimo Dell'Antonia  1 , Speranza Anedda  1 , Federica Usai  1 , Laura Atzori  1 , Caterina Ferreli  1
Affiliations

Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy

Massimo Dell'Antonia et al. Dermatol Ther. 2022 Jan.
No abstract available

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Erosions and blisters on the left leg (A); complete resolution after 3 weeks of treatment (B)
See this image and copyright information in PMC

References

    1. Jindal A, Nayak SUK, Shenoi SD, Rao R, Monappa V. Bullous pemphigoid triggered by rabies vaccine. Indian J Dermatol Venereol Leprol. 2020. Jan‐Feb;86(1):66‐68. doi:10.4103/ijdvl.IJDVL_666_18 - DOI - PubMed
    1. Maki N, Hashimoto T, Yamada T, Ishii N, Tsuruta D, Demitsu T. Case of pemphigoid with immunoglobulin G antibodies to BP180 C‐terminal domain and laminin‐γ1 (p200) developed after pneumococcal vaccination. J Dermatol. 2021;48(1):101‐105. doi:10.1111/1346-8138.15626 - DOI - PubMed
    1. Baroero L, Coppo P, Bertolino L, Maccario S, Savino F. Three case reports of post immunization and post viral bullous pemphigoid: looking for the right trigger. BMC Pediatr. 2017;17(1):60. doi:10.23736/S0392-0488.18.06006-6 - DOI - PMC - PubMed
    1. Cozzani E, Marzano AV, Caproni M, Feliciani C, Calzavara‐Pinton P. Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines. G Ital Dermatol Venereol. 2018;153(3):305‐315. doi:10.23736/S0392-0488.18.06006-6 - DOI - PubMed
    1. Chung JY, Thone MN, Kwon YJ. COVID‐19 vaccines: the status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2021;170:1‐25. doi:10.1016/j.addr.2020.12.011 - DOI - PMC - PubMed